Assuta Medical Center
| イスラエル | トルコ | オーストリア | |
| 精巣摘除術 | から $5,800 | から $2,889 | から $9,000 |
| 睾丸プロテーゼ | から $6,500 | から $1,500 | から $3,500 |
| 乳癌化学療法 | から $22,500 | から $1,200 | から $15,000 |
| 精巣腫瘍摘出術 | - | から $4,500 | から $8,500 |
| 精巣癌放射線治療 | - | から $4,800 | から $6,969 |
メリムスキー教授は、ソウラスキー医療センターの軟部組織・骨腫瘍ユニットを率い、希少がんを専門としています。
この医師は化学療法と放射線療法の専門家であり、乳がん、子宮がん、前立腺がん、消化管がん、肺がん、腎臓がん、膀胱がんを含む様々な腫瘍性疾患の治療に焦点を当てています。医師は化学療法、放射線療法、生物学的がん治療などの先進的な治療法を用い、がん治療後のリハビリテーションも提供しています。
1988年からの経験を持ち、2009年からSourasky (Ichilov) Medical Centerで上級腫瘍専門医として勤務しており、Rambam Medical CenterおよびSourasky Medical Centerで重要な役職を歴任しています。医師は30以上の科学論文に貢献しており、がん治療の臨床試験にも関与しています。
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).
His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.
He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.
He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.
Israel treats testicular cancer using radical inguinal orchiectomy as the primary surgical standard. Specialized centers like Sourasky Medical Center report survival rates between 90% and 95%. Advanced protocols include robotic assisted retroperitoneal lymph node dissection and high dose chemotherapy with stem cell support.
Bookimed Expert Insight: Israeli oncology centers like Sheba and Sourasky handle massive patient volumes, with Sheba treating 1.9 million patients annually. This scale allows surgeons to specialize narrowly in rare urological cancers. While many patients focus on the initial surgery, the long-term benefit in Israel is the integration of genetic profiling and CAR-T technology available at sites like Sheba for resistant cases.
Patient Consensus: Patients often emphasize the relief of having a multidisciplinary team manage everything from prosthetic implants to post-cancer rehabilitation. Many note that the speed of diagnostic PET-CT scans in Tel Aviv and Jerusalem was crucial for their peace of mind.
Testicular cancer treatments like orchiectomy typically preserve fertility if one healthy testicle remains. However, chemotherapy, radiation, and extensive surgeries like nerve-sparing lymphadenectomy may impact sperm production or delivery. Experts recommend banking sperm before starting these systemic or pelvic therapies to ensure future reproductive options.
Bookimed Expert Insight: While most patients focus on the surgery, our data from Sourasky Medical Center suggests the most significant recovery window is the first 18 months post-chemotherapy. Choosing a specialist like Dr. Zohar Dotan, who leads the Israeli Uro-Oncology Society, ensures access to nerve-sparing protocols that protect the physical ability to conceive naturally while treating the primary tumor.
Patient Consensus: Patients emphasize banking sperm even if the oncologist seems optimistic. They note that natural conception is common after surgery alone, but semen analysis at 6-month intervals is vital after chemotherapy.
Surgery for testicular cancer in Israel preserves physical appearance and sexual function through advanced nerve-sparing techniques and cosmetic reconstruction. Most patients maintain normal erections and sensation after unilateral orchiectomy. Options like testicular prosthetics and minimally invasive robotic procedures help ensure symmetrical aesthetic results and faster physical recovery.
Bookimed Expert Insight: Israeli oncology centers like Sheba and Sourasky prioritize organ-preserving and nerve-sparing approaches to protect future fertility and sexual health. Dr. Zohar Dotan and Dr. Jack Baniel specialize in robotic urology, which reduces tissue trauma compared to traditional surgery. Data shows that Choosing a surgeon who performs high volumes of these precise procedures significantly increases the likelihood of maintaining normal ejaculatory function.
Patient Consensus: Patients note that the surgical scar becomes nearly invisible over time and doesn't show through swimwear. Many emphasize that while libido might dip briefly during recovery, full sexual function typically returns within three months.
Organ-preserving surgery is an option in Israel for specific cases of testicular cancer. This procedure, known as partial orchiectomy, prioritizes hormonal and reproductive function. It is primarily considered for small, non-palpable masses or patients with a single functioning testicle.
Bookimed Expert Insight: Israeli oncology centers like Sourasky and Sheba Medical Center serve over 1.8 million patients annually. Their high surgical volume allows for specialized histopathology revision of prior biopsies. This second opinion often determines if an organ-sparing approach is safe before surgery begins. It is a critical step for patients seeking to avoid lifelong hormone replacement therapy.
Patient Consensus: Patients value the high level of attentiveness at private centers like Assuta Medical Center. They note that choosing their own attending surgeon provides significant peace of mind during complex procedures.
During your first consultation in Israel, ask about nerve-preserving surgical techniques and the experience of your uro-oncologist. Clarify your specific tumor markers like AFP and HCG. Confirm the staging and discuss fertility preservation options. Israeli centers often use robotic-assisted methods for complex procedures.
Bookimed Expert Insight: Our data shows Israeli oncology centers like Sheba and Sourasky operate with massive patient volumes, often exceeding 1,000,000 annually. This high volume allows doctors like Dr. Zohar Dotan to specialize in niche, organ-preserving robotic surgeries. When booking your visit, check if the clinic possesses JCI accreditation. It ensures the facility meets strict global safety standards for complex cancer procedures.
Patient Consensus: Patients emphasize the need to discuss long-term testosterone impacts and sexual function early. Many suggest bringing a companion to help track details during fast-paced medical discussions.
Private hospitals in Israel typically start testicular cancer diagnostics within 4 to 5 working days. State hospitals often face longer queues. Public specialist consultations may take 24 to 40 days. Choosing private facilities allows patients to schedule surgeries immediately after diagnosis.
Bookimed Expert Insight: Data shows high-volume centers like Assuta Medical Center perform 92,000 operations annually. This massive scale allows private facilities to bypass the 40-day public waits seen in Tel Aviv. Patients often choose these centers specifically to select their own surgeon and room type.
Patient Consensus: Patients note that the speed of private care reduces the anxiety of waiting. Many emphasize that having a pre-organized program helps manage logistics smoothly during urgent treatments.